Peter Horby to Research Design
This is a "connection" page, showing publications Peter Horby has written about Research Design.
Connection Strength
0.622
-
GOST: A generic ordinal sequential trial design for a treatment trial in an emerging pandemic. PLoS Negl Trop Dis. 2017 03; 11(3):e0005439.
Score: 0.205
-
CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement. Influenza Other Respir Viruses. 2017 01; 11(1):2-14.
Score: 0.196
-
Core Outcome Measures for Trials in People With Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and Recovery. Crit Care Med. 2021 03 01; 49(3):503-516.
Score: 0.067
-
Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009. BMC Med. 2020 08 21; 18(1):265.
Score: 0.065
-
Regulatory and Operational Complexities of Conducting a Clinical Treatment Trial During an Ebola Virus Disease Epidemic. Clin Infect Dis. 2018 04 17; 66(9):1454-1457.
Score: 0.055
-
International Survey to Establish Prioritized Outcomes for Trials in People With Coronavirus Disease 2019. Crit Care Med. 2020 11; 48(11):1612-1621.
Score: 0.016
-
Core Outcomes Set for Trials in People With Coronavirus Disease 2019. Crit Care Med. 2020 11; 48(11):1622-1635.
Score: 0.016